CRAI vs. MDXG

Last updated Jun 3, 2026

CRAI (CRA International, Inc.) and MDXG (MiMedx Group, Inc.) are both stocks. CRAI operates in Consulting Services (Industrials), while MDXG operates in Medical Devices (Healthcare). Over the past 10 years, CRAI returned 21.39%/yr vs -7.99%/yr for MDXG. At a 0.14 correlation, their price movements are largely independent.

Performance

CRAI vs. MDXG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CRA International, Inc. (CRAI) and MiMedx Group, Inc. (MDXG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRAI achieves a -27.79% return, which is significantly higher than MDXG's -47.27% return. Over the past 10 years, CRAI has outperformed MDXG with an annualized return of 21.39%, while MDXG has yielded a comparatively lower -7.99% annualized return.

CRAI

• 1D: -1.95%
• 1M: -10.74%
• YTD: -27.79%
• 6M: -20.90%
• 1Y: -23.30%
• 3Y*: 15.70%
• 5Y*: 12.77%
• 10Y*: 21.39%

MDXG

• 1D: -0.28%
• 1M: -2.99%
• YTD: -47.27%
• 6M: -46.88%
• 1Y: -44.13%
• 3Y*: -14.84%
• 5Y*: -19.16%
• 10Y*: -7.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRAI vs. MDXG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRAI CRA International, Inc.	-27.79%	8.68%	91.38%	-18.07%	32.94%	85.67%	-4.47%	30.42%	-4.04%	24.75%
MDXG MiMedx Group, Inc.	-47.27%	-29.63%	9.69%	215.47%	-53.97%	-33.48%	19.79%	323.46%	-85.80%	42.33%

Correlation

The correlation between CRAI and MDXG is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.25
Correlation (3Y) Calculated over the trailing 3-year period	0.27
Correlation (5Y) Calculated over the trailing 5-year period	0.31
Correlation (10Y) Calculated over the trailing 10-year period	0.18
Correlation (All Time) Calculated using the full available price history since Aug 23, 2007	0.14

The correlation between CRAI and MDXG shifts across timeframes, from 0.14 (all time) to 0.31 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CRAI : $947.88M MDXG : $529.95M
EPS CRAI : $7.21 MDXG : $0.21
PE Ratio CRAI : 19.96 MDXG : 17.36
PEG Ratio CRAI : 1.82 MDXG : 0.00
PS Ratio CRAI : 1.24 MDXG : 1.37
PB Ratio CRAI : 4.78 MDXG : 2.18
Total Revenue (TTM) CRAI : $770.71M MDXG : $389.42M
Gross Profit (TTM) CRAI : $156.66M MDXG : $315.59M
EBITDA (TTM) CRAI : $95.16M MDXG : $53.81M

Return for Risk

CRAI vs. MDXG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRAI

CRAI Risk / Return Rank: 15
CRAI Sharpe Ratio Rank: 13
CRAI Sortino Ratio Rank: 16
CRAI Omega Ratio Rank: 16
CRAI Calmar Ratio Rank: 18
CRAI Martin Ratio Rank: 11

MDXG

MDXG Risk / Return Rank: 7
MDXG Sharpe Ratio Rank: 4
MDXG Sortino Ratio Rank: 5
MDXG Omega Ratio Rank: 6
MDXG Calmar Ratio Rank: 13
MDXG Martin Ratio Rank: 5

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRAI vs. MDXG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CRA International, Inc. (CRAI) and MiMedx Group, Inc. (MDXG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRAI	MDXG	Difference
Sharpe ratio Return per unit of total volatility	-0.63	-1.04	+0.40
Sortino ratio Return per unit of downside risk	-0.69	-1.56	+0.86
Omega ratio Gain probability vs. loss probability	0.91	0.82	+0.10
Calmar ratio Return relative to maximum drawdown	-0.61	-0.73	+0.12
Martin ratio Return relative to average drawdown	-1.26	-1.49	+0.23
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRAI vs. MDXG - Sharpe Ratio Comparison

The current CRAI Sharpe Ratio is -0.63, which is higher than the MDXG Sharpe Ratio of -1.04. The chart below compares the historical Sharpe Ratios of CRAI and MDXG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRAI	MDXG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.63	-1.04	+0.40
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.37	-0.31	+0.68
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.55	-0.11	+0.66
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.06	+0.10

Drawdowns

CRAI vs. MDXG - Drawdown Comparison

The maximum CRAI drawdown since its inception was -76.40%, smaller than the maximum MDXG drawdown of -93.83%. Use the drawdown chart below to compare losses from any high point for CRAI and MDXG.

Drawdown Indicators

	CRAI	MDXG	Difference
Max Drawdown Largest peak-to-trough decline	-76.40%	-93.83%	+17.43%
Max Drawdown (1Y) Largest decline over 1 year	-38.12%	-61.24%	+23.12%
Max Drawdown (3Y) Largest decline over 3 years	-38.12%	-68.36%	+30.24%
Max Drawdown (5Y) Largest decline over 5 years	-38.12%	-83.39%	+45.27%
Max Drawdown (10Y) Largest decline over 10 years	-60.74%	-93.60%	+32.86%
Current Drawdown Current decline from peak	-35.11%	-80.12%	+45.01%
Average Drawdown Average peak-to-trough decline	-33.47%	-53.50%	+20.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.33%	29.79%	-11.46%

Volatility

CRAI vs. MDXG - Volatility Comparison

CRA International, Inc. (CRAI) has a higher volatility of 17.04% compared to MiMedx Group, Inc. (MDXG) at 8.66%. This indicates that CRAI's price experiences larger fluctuations and is considered to be riskier than MDXG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRAI	MDXG	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.04%	8.66%	+8.38%
Volatility (6M) Calculated over the trailing 6-month period	30.92%	30.99%	-0.07%
Volatility (1Y) Calculated over the trailing 1-year period	37.04%	42.76%	-5.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	34.70%	62.11%	-27.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	38.74%	73.92%	-35.18%

Dividends

CRAI vs. MDXG - Dividend Comparison

CRAI's dividend yield for the trailing twelve months is around 1.87%, while MDXG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
CRAI CRA International, Inc.	1.87%	1.26%	0.93%	1.52%	1.05%	1.17%	1.87%	1.52%	1.67%	1.31%	0.38%
MDXG MiMedx Group, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

CRAI vs. MDXG - Profitability Comparison

The chart below illustrates the profitability comparison between CRA International, Inc. and MiMedx Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CRAI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CRA International, Inc. reported a gross profit of 0.00 and revenue of 200.98M. Therefore, the gross margin over that period was 0.0%.

MDXG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported a gross profit of 41.62M and revenue of 58.99M. Therefore, the gross margin over that period was 70.6%.

CRAI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CRA International, Inc. reported an operating income of 18.03M and revenue of 200.98M, resulting in an operating margin of 9.0%.

MDXG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported an operating income of -16.05M and revenue of 58.99M, resulting in an operating margin of -27.2%.

CRAI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CRA International, Inc. reported a net income of 11.13M and revenue of 200.98M, resulting in a net margin of 5.5%.

MDXG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported a net income of -10.86M and revenue of 58.99M, resulting in a net margin of -18.4%.

Frequently Asked Questions

Can I hold both CRAI and MDXG in my portfolio?

CRAI and MDXG have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRAI or MDXG?

CRAI has higher volatility (17.04%) compared to MDXG (8.66%). In terms of maximum drawdown, CRAI dropped -76.40% vs MDXG's -93.83%.

Which has better risk-adjusted returns?

CRAI currently has the higher Sharpe Ratio (-0.63 vs -1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.